Grifols S.A. ADR (GRFS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1585 BROADWAY NEW YORK, NY 10036

BUSINESS: Grifols is in the forefront of all their areas of activity: they investigate, they develop and they market life-saving plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems which improve healthcare and peoples wellbeing. Since their early beginnings, given the nature of the products they sells, Grifols maintains a very close relationship with professionals from different hospital areas. Grifols helps medical and healthcare professionals to take care of peoples health by offering innovative products and excellent service.

Data as of 2020-09-12
Market Cap10.836 Billion Shares Outstanding684.54 Million Avg 30-day Volume1.355 Million
P/E Ratio18.6 Dividend Yield2.144 EPS0.94
Price/Sales2.024 Price cash flow ratio10.1 Price free cash flow ratio50.9
Book Value9.25 Price to Tangible Book-6.47 Alpha-0.0
Short Interest Ratio % Short Interest to Float R-squared0.190482
BETA0.697579 52-week High/Low25.73 / 13.4 Stddev0.068293
View SEC Filings from GRFS instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 8 -37.5% 1 (0.07%) 2 (0.13%) -50.0%
Funds Holding: 181 182 -0.55% 45 (2.94%) 46 (2.94%) -2.17%
13F shares: 123.235 Million 123.431 Million -0.16% 27.782 Million 38.874 Million -28.53%
% Ownership 18.0026 17.9522 0.28% 4.0585 5.654 -28.22%
New Positions: 30 27 11.11% 12 9 33.33%
Increased Positions 63 59 6.78% 12 13 -7.69%
Closed Positions 30 33 -9.09% 13 9 44.44%
Reduced Positions 60 69 -13.04% 14 20 -30.0%
Total Calls 13.401 Thousand 75.508 Thousand -82.25%
Total Puts 10.4 Thousand 52.101 Thousand -80.04%
PUT/CALL Ratio 0.78 0.69 13.04% 13.04%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding GRFS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GRFS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments